Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04899895 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Rheumatology Biorepository

StatusEnrolling by Invitation
PhaseNot specified
SponsorCorEvitas
Started
View on ClinicalTrials.gov ↗

Record History

  1. Minor 3 versions Re-verified since Nov 9, 2022, no change to tracked fieldsv2-v4
  2. Minor Study First Submitted
The Biorepository is a prospective observational cohort study for patients under the care of a licensed physician or qualified physician extender. Target minimum enrollment is approximately 3,000 patients within the first 5 years of the study with no defined upper limit of enrollment. Sites from Corrona's current North America network will be asked to participate. Participating sites and subjects will not receive results from any laboratory testing conducted on the Samples. Personal identifying information will not be collected along with the Samples. Subjects will provide informed consent to contribute Samples to include blood (serum, plasma, whole blood) to the Biorepository. In the future, Subjects may be asked to contribute other samples (i.e. saliva, urine, stool) and an additional informed consent will be obtained. Subjects will retain the right to withdraw their consent for use of their Samples at any time. In such case, Corrona will destroy any unused/remaining Samples in its possession.
Trial Details
NCT Number NCT04899895
Lead Sponsor CorEvitas
Conditions
(from sponsor)
Rheumatoid Arthritis
Related terms Arthritis, Rheumatoid
Enrollment 3,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov